載入...
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
Patients with cytogenetically normal acute myeloid leukemia (CN-AML) show heterogeneous treatment outcomes. We used gene-expression profiling to develop a gene signature that predicts overall survival (OS) in CN-AML. Based on data from 163 patients treated in the German AMLCG 1999 trial and analyzed...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2954679/ https://ncbi.nlm.nih.gov/pubmed/18716133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-134411 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|